Literature DB >> 7875756

Association of the alpha-adducin locus with essential hypertension.

G Casari1, C Barlassina, D Cusi, L Zagato, R Muirhead, M Righetti, P Nembri, K Amar, M Gatti, F Macciardi.   

Abstract

Previous studies on genetic rat hypertension have shown that polymorphism within the alpha-adducin gene may regulate blood pressure. Adducin is a cytoskeletal protein that may be involved in cellular signal transduction and interacts with other membrane-skeleton proteins that affect ion transport across the cell membrane. There is a high homology between rat and human adducin and pathophysiological similarities between the Milan hypertensive rat strain and a subgroup of patients with essential hypertension. Thus, we designed a case-control study to test the possible association between the alpha-adducin locus and hypertension. One hundred ninety primary hypertensive patients were compared with 126 control subjects. All subjects were white and unrelated. Four multiallelic markers surrounding the alpha-adducin locus located in 4p16.3 were selected: D4S125 and D4S95 mapping at 680 and 20 kb centromeric, and D4S43 and D4S228/E24 mapping at 660 and 2500 kb telomeric. Alleles for each marker were pooled into groups. Comparisons between control subjects and hypertensive patients were carried out by testing the allele-disease association relative to the marker genotype. The maximal association occurred for D4S95 (chi 2(1) 13.33), which maps closest to alpha-adducin. These data suggest that a polymorphism within the alpha-adducin gene may affect blood pressure in humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7875756     DOI: 10.1161/01.hyp.25.3.320

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  28 in total

Review 1.  Gene-environment interactions in hypertension.

Authors:  Z Pausova; J Tremblay; P Hamet
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

Review 2.  Use of single nucleotide polymorphisms for gene discovery in hypertension.

Authors:  M Fornage; P A Doris
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

3.  Identification of adducin-binding residues on the cytoplasmic domain of erythrocyte membrane protein, band 3.

Authors:  Taina Franco; Haiyan Chu; Philip S Low
Journal:  Biochem J       Date:  2016-07-19       Impact factor: 3.857

Review 4.  Personalized Therapy of Hypertension: the Past and the Future.

Authors:  Paolo Manunta; Mara Ferrandi; Daniele Cusi; Patrizia Ferrari; Jan Staessen; Giuseppe Bianchi
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

Review 5.  Hypertensive epigenetics: from DNA methylation to microRNAs.

Authors:  J Wang; L Gong; Y Tan; R Hui; Y Wang
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

6.  New target regions for human hypertension via comparative genomics.

Authors:  M Stoll; A E Kwitek-Black; A W Cowley; E L Harris; S B Harrap; J E Krieger; M P Printz; A P Provoost; J Sassard; H J Jacob
Journal:  Genome Res       Date:  2000-04       Impact factor: 9.043

7.  Lack of renal dopamine D5 receptors promotes hypertension.

Authors:  Laureano Asico; Xiaojie Zhang; Jifu Jiang; David Cabrera; Crisanto S Escano; David R Sibley; Xiaoyan Wang; Yu Yang; Roslyn Mannon; John E Jones; Ines Armando; Pedro A Jose
Journal:  J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 10.121

Review 8.  The genomics of cardiovascular disorders: therapeutic implications.

Authors:  P Ferrari; G Bianchi
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

9.  Sorting nexin 1 loss results in increased oxidative stress and hypertension.

Authors:  Jian Yang; Laureano D Asico; Amber L Beitelshees; Jun B Feranil; Xiaoyan Wang; John E Jones; Ines Armando; Santiago G Cuevas; Gary L Schwartz; John G Gums; Arlene B Chapman; Stephen T Turner; Eric Boerwinkle; Rhonda M Cooper-DeHoff; Julie A Johnson; Robin A Felder; Edward J Weinman; Chunyu Zeng; Pedro A Jose; Van Anthony M Villar
Journal:  FASEB J       Date:  2020-04-15       Impact factor: 5.191

10.  Alpha-adducin Gly460Trp polymorphism and hypertension risk: a meta-analysis of 22 studies including 14303 cases and 15961 controls.

Authors:  Kuo Liu; Jielin Liu; Yan Huang; Ya Liu; Yuqing Lou; Zuoguang Wang; Hong Zhang; Shan Yan; Zhizhong Li; Shaojun Wen
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.